The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects
about
Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imagingPHD inhibition mitigates and protects against radiation-induced gastrointestinal toxicity via HIF2.Rationale for using multiple antioxidants in protecting humans against low doses of ionizing radiation.Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy.Pterisolic Acid B is a Nrf2 Activator by Targeting C171 within Keap1-BTB Domain.Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats.Effects of Fructus Piperis Longi extract on fibrotic liver of gamma-irradiated rats.Aiming at neuroblastoma and hitting other worthy targets.Development of highly effective three-component cytoprotective adjuncts for cisplatin cancer treatment: synthesis and in vivo evaluation in S180-bearing mice.Radioprotective effect of amifostine on cells from cancer prone patients and healthy individuals studied by the G2 and PCC assays.Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes.Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies.The in vitro protective effect of salicylic acid against paclitaxel and cisplatin-induced neurotoxicityComparative toxic effect of nitrogen mustards (HN-1, HN-2, and HN-3) and sulfur mustard on hematological and biochemical variables and their protection by DRDE-07 and its analogues.Structure-activity analysis of the potentiation by aminothiols of the chromosome-damaging effect of bleomycin in G0 human lymphocytes.Differential antigenotoxic and cytoprotective effect of amifostine in idarubicin-treated mice.Flow cytometric detection of apoptotic bone marrow cells with fractional DNA content after application of WR-2721, cyclophosphamide, cisplatin, and exposure of mice to gamma rays.In vivo protection by amifostine and DRDE-07 against sulphur mustard toxicity.Amifostine prior to lethal irradiation prevents allogeneic bone marrow engraftment in mice.Effects of yak-activated protein on hematopoiesis and related cytokines in radiation-induced injury in mice.Reduction of doxorubicin-induced genotoxicity by Handroanthus impetiginosus in mouse bone marrow revealed by micronucleus assay.Prophylactic efficacy of S-2(2-aminoethylamino)ethyl phenyl sulfide (DRDE-07) against sulfur mustard induced lung toxicity in mice.Chronomodulated chemotherapy: clinical value and possibilities for dissemination in the United States.Examination of the effect of ovarian radiation injury induced by hysterosalpingography on ovarian proliferating cell nuclear antigen and the radioprotective effect of amifostine: an experimental study.Glutathione S -transferase π: a potential role in antitumor therapy
P2860
Q30240026-60038E1F-AD9B-46FB-A5BA-8F67F5CDE233Q33751114-4FF44EE5-1A98-4776-AEE4-EAFD1F4695CFQ34060109-EB01EFEC-0DFA-45A7-AECF-D38D6A6531BEQ36130868-55140C75-72FA-4771-A663-5D93599B437AQ36458432-315A4E4E-9931-4683-8518-A34ACC5BBB75Q36497820-1E345C64-C953-441D-8BB5-32AD5942AA04Q36544184-700A367A-1126-4142-9A96-3115E2DC77E5Q36697108-D948CD60-0142-4461-9CA4-98B95E814B87Q37132057-111F1868-B1C8-40E4-812A-A30D432A31B1Q38098145-360051B4-A049-4268-978F-C9D8E57C1C48Q39541239-60D8951C-E3AA-45D6-87DC-9901CD9FE907Q40614865-2059F072-4E5B-4DE1-8592-D10131DA23CCQ42130904-AA52517B-6F5C-4B2A-8157-F98277FC99C3Q42361422-945E231D-2226-4B36-8AE0-970918551359Q42405747-C0C917B6-03F9-4898-AC2E-0148E1A46F56Q43064133-5DFB1FCB-E4E6-49B0-8A48-A521DB392A66Q43540960-B30152DD-8883-4960-8162-CF4F11B8D7BFQ43867902-5EC83C10-B69C-4D91-ADCE-080D90BD3653Q44114351-8F05F73E-9545-47CA-9779-E3200105DF0FQ44147968-F6C24F89-6E87-4009-8494-F6EFC220326DQ46774793-77FD5188-B4B1-4765-AE9E-9FD4AC1CE382Q47116685-6E6EA94D-185C-4B28-84D8-8288E7493A72Q50533614-BEE773C5-1E98-4459-8DCE-AB317A995166Q52926329-67B2DA2F-8A0D-4A1B-8B57-A140A006E987Q52938932-32EAC4BA-FBE6-44D4-8636-FE7080CB6FC6Q55255721-CB569ADA-B6BC-412A-9374-537411102D7FQ58694500-DE4E023B-4826-4A55-9BBB-37DFB778DC4C
P2860
The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The sulfhydryl containing comp ...... ications for use and prospects
@ast
The sulfhydryl containing comp ...... ications for use and prospects
@en
type
label
The sulfhydryl containing comp ...... ications for use and prospects
@ast
The sulfhydryl containing comp ...... ications for use and prospects
@en
prefLabel
The sulfhydryl containing comp ...... ications for use and prospects
@ast
The sulfhydryl containing comp ...... ications for use and prospects
@en
P2093
P2860
P356
P1476
The sulfhydryl containing comp ...... ications for use and prospects
@en
P2093
Eisenhauer EA
Hospers GA
de Vries EG
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690404
P407
P577
1999-05-01T00:00:00Z
P5875
P6179
1036206005